Diabetic Nephropathy
Open Access
- 1 January 2003
- journal article
- guideline
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (suppl_1), s94-s98
- https://doi.org/10.2337/diacare.26.2007.s94
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Treatment of Hypertension in Adults With DiabetesDiabetes Care, 2003
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesThe New England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyThe New England Journal of Medicine, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyThe New England Journal of Medicine, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993